The plasminogen activator system in women with polycystic ovary syndrome

Fertility and Sterility

Volumn 69, Issue 2, 1998, Pages 236-241

  Atiomo, William U ^a,b   Bates, Susie A ^a,c   Condon, John E ^a   Shaw, Steve ^a,b   West, Jonathan H ^d   Prentice, Archibald G ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

^c London Fertility Centre   (United Kingdom)

^d ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

Ovulation; Plasmin; Plasminogen activator inhibitor 1; Polycystic ovary syndrome

Indexed keywords

ADULT; ANOVULATION; ARTICLE; BLEEDING TIME; BLOOD CLOT LYSIS; BLOOD CLOTTING; CLINICAL ARTICLE; FEMALE; HUMAN; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ADULT; ANTIPLASMIN; BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; FEMALE; FIBRINOGEN; HORMONES; HUMANS; PHLEBOTOMY; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYCYSTIC OVARY SYNDROME; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0031931603     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)00486-X     Document Type: Article

References (28)

1. Hull, MGR. Epidemiology of infertility and polycystic ovarian disease: Endocrinological and demographic studies. Gynecol Endocrinol 1987;28:700-3.
2. Adams J, Poison DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986;293:355-9.
3. Sagle M, Bishop K, Ridley N, Alexander FM, Michael M, Bonney RC, et al. Recurrent early miscarriage and polycystic ovaries. Br Med J 1988;297:1027-8.
4. Yen SSC. Chronic anovulation caused by peripheral endocrine disorders. In: Yen SSC, Jaffe R, editors. Reproductive endocrinology. Philadelphia: Saunders, 1986:441-99.
5. Franks S, Adams J, Mason H, Poison D. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol 1985;12:605-32.
6. Eschel A, Abdulwahid NA, Armar NA, Adams J, Jacobs HS. Pulsatile luteinizing hormone releasing hormone therapy in the polycystic ovary syndrome. Fertil Steril 1988;49:956-60.
7. Dunaif A, Segal K, Futterweit W, Dobrjansky K. Profound insulin resistance independent of obesity in polycystic ovary syndrome. Diabetes 1989;38:1165-73.
8. Avellone G, Di Garbo V, Cordova R, Rotolo G, Abruzzese G, Raneli G, et al. Blood coagulation and fibrinolysis in Obese NIDDM patients. Diabetes Res 1994;25:85-92.
9. Juhan-Vague C, Roul MC, Alesi JP, Ardissone M, Heim M, Vague P. Increased plasminogen activator inhibitor activity in non insulin dependent diabetes - relationship with plasma insulin. Thromb Hhaemost 1989;61(3):370-3.
10. Francis C, Marder V. Mechanisms of fibrinolysis. In: Beutler E, Licthman M, Coller B, Kipps T, editors. Williams Haematology. New York: McGraw Hill; 1995:1252-60.
11. Piquette GN, Crabtree ME, Imam E-D, Milki A, Polan L. Regulation of plasminogen activator inhibitor-1 and -2 messenger ribonucleic acid levels in human cumulus and granulosa-luteal cells. J Clin Endocrinol Metab 1993;76:518-23.
12. Beers WH. Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall. Cell 1975;6:379-86.
13. Puistola U, Westerlund A, Kauppila A, Turpeenniemi-Hujanen T. Regulation of 72-kd type IV collagenase-matrix metalloproteinase-2 by estradiol and gonadotropin-releasing hormone agonist in human granulosa-lutein cells. Fertil Steril 1995;64:81-7.
14. Sappino A-P, Huarte J, Belin D, Vassali J-D. Plasminogen activators in tissue remodelling and Invasion: mRNA Localisation in mouse ovaries and implanting embryos. J Cell Biol 1989;109:2471-9.
15. Andolf E, Casslen B, Jorgensen C, Buchhave P, Lecander I. Fluid characteristics of benign ovarian cysts: Correlation with recurrence after puncture. Obstet Gynecol 1995;86:529-35.
16. Dahlgren E, Jansen OP, Johansson S, Lapidus L, Lindstedt G, Tengborn L. Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril 1994;61:455-60.
17. Anderson P, Seljeflo I, Abdelnoor M, Arnesen H, Dale PO, Lovik A, et al. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism: Clinical & Experimental 1995;44(5):611-16.
18. Swanson M, Sauerbrei EE, Cooperage PL. Medical implications of ultrasonocally detected polycystic ovaries. J Clin Ultrasound 1981;9:219-22.
19. Juhan-Vague I, Alessi MC, Raccah D, Ailluad MF, Billery M, Ansaldi J, et al. Daytime fluctuations of plasminogen activator inhibitor-1 (PAI-1) in populations with high PAI-1 levels. Thromb Haemost 1992;67(1):76-82.
20. Ferriman D, Gallwey J. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-5.
21. Dacie JV, Lewis SM. Practical haematology. 8th ed. New York: Churchill Livingstone. 1995;357-8.
22. Gris J-C, Neveu S, Mares P, Biron C, Hedon B, Schved J-F. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown aetiology. J Lab Clin Med 1993:122(5):606-15.
23. Vague P, Juhan-Vague I, Chaber V, Alessi MC, Atlan C. Fat distribution and plasminogen activator inhibitor activity in non-diabetic women. Metabolism 1989;38:913-5.
24. Sampson M, Kong C, Patel A, Unwin R, Jacobs HS. Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) in lean women with and without the polycystic ovary syndrome. Clin Endocrinol 1996;45:623-9.
25. Meade TW, Cooper JA, Chakrabarti R, Miller GJ, Stirling Y, Howarth DJ. Fibrinolytic activity and clotting factors in ischaemic heart disease in women. Br Med J 1996;312:1581.
26. Wild RA, Van Nort JJ, Grubb B, Bachman W, Hartz A, Bartholomew M. Clinical signs of androgen excess in as risk factors for coronary heart disease. Fertil Steril 1990;61:946.
27. Patrassi GM, Sartori MT, Ruffatti A, Viero M, Di Leonardo L, Cazzanello D, et al. Fibrinolytic pattern in recurrent spontaneous abortions: no relationship between hypofibrinolysis and anti-phospholipid antibodies. Am J Hematol 1994;47:26-72.
28. Clifford K, Rai R, Watson H, Franks, Regan L. Does suppressing luteinizing hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. Br Med J 1996;312:1508-11.